Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Shares Outstanding (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Shares Outstanding for 13 consecutive years, with $2.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 258553100.0% to $2.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.6 million, a 258553100.0% increase, with the full-year FY2024 number at $1.7 million, up 22.17% from a year prior.
  • Shares Outstanding was $2.6 million for Q3 2025 at Creative Medical Technology Holdings, roughly flat from $2.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $3.0 million in Q3 2021 to a low of $1.0 in Q2 2024.
  • A 5-year average of $1.4 million and a median of $1.4 million in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: plummeted 100.0% in 2024, then soared 258553100.0% in 2025.
  • Creative Medical Technology Holdings' Shares Outstanding stood at $633886.0 in 2021, then surged by 122.06% to $1.4 million in 2022, then rose by 1.67% to $1.4 million in 2023, then grew by 22.17% to $1.7 million in 2024, then surged by 47.88% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Shares Outstanding are $2.6 million (Q3 2025), $2.6 million (Q2 2025), and $2.6 million (Q1 2025).